Genotype-Phenotype Studies of Six Novel LPL Mutations in Chinese Patients with Hypertriglyceridemia

被引:17
作者
Chan, Lisa Y. S. [1 ]
Lam, Ching-Wan [1 ]
Mak, Ying-Tat [1 ]
Tomlinson, Brian [2 ]
Tsang, Man-Woo [4 ]
Baum, Larry [2 ]
Masarei, John R. L. [5 ]
Pang, Chi-Pui [3 ]
机构
[1] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China
[4] United Christian Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
lipoprotein lipase; LPL; hypertriglyceridemia; Chinese;
D O I
10.1002/humu.9054
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We screened 160 unrelated Chinese hypertriglyceridemic subjects for sequence alterations in the promoter and the 10 exons of the lipoprotein lipase (LPL) gene. We identified one reported mutation (L252R), one common polymorphism (S447X), and six novel mutations: V181I, C283Y, S298R and S338F (found in single individuals), L252V (in two individuals), and A71T (in three individuals). Screening of family members of the above probands revealed a total of 19 mutation carriers, most of whom, though not all, displayed reduced LPL activity and mass when compared to normolipidemic control subjects. In in vitro expression studies, A71T, V181I, L252R, L252V and C283Y decreased the specific activity of the gene product. Interestingly, S298R had no effect on the catalytic activity while S338F increased it. A71T and C283Y reduced the secretion of the mutant proteins significantly while V181I, S298R and S338F had mild effects only. The total LPL mass of all the mutant constructs was reduced compared to that of the wild type construct, probably due to the instabilities of the mutant mRNA or the mutant protein. The heterogeneity in phenotypic effects of these mutations is a likely consequence of their variable effects on proteoglycan binding, conformation and interactions with other secondary genetic or environmental factors. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:232 / 233
页数:9
相关论文
共 33 条
[1]   Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene [J].
Benlian, P ;
DeGennes, JL ;
Foubert, L ;
Zhang, HF ;
Gagne, SE ;
Hayden, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :848-854
[2]  
BRUIN T, 1993, J LIPID RES, V34, P2109
[3]  
BRUNZELL JD, 1995, METABOLIC BASIS INHE, V2, P1913
[4]  
Chan L, 2000, EUR J CLIN INVEST, V30, P33
[5]  
Enholm C, 1986, METHOD ENZYMOL, P716
[6]   Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis [J].
Fisher, RM ;
Humphries, SE ;
Talmud, PJ .
ATHEROSCLEROSIS, 1997, 135 (02) :145-159
[7]  
Fojo SS, 1994, CURR OPIN LIPIDOL, V5, P117
[8]  
Foubert L, 1997, HUM MUTAT, V10, P179
[9]   ANALYSIS OF DNA CHANGES IN THE LPL GENE IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA [J].
GAGNE, E ;
GENEST, J ;
ZHANG, H ;
CLARKE, LA ;
HAYDEN, MR .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (08) :1250-1257
[10]   HETEROGENEOUS MUTATIONS IN THE HUMAN LIPOPROTEIN-LIPASE GENE IN PATIENTS WITH FAMILIAL LIPOPROTEIN-LIPASE DEFICIENCY [J].
GOTODA, T ;
YAMADA, N ;
KAWAMURA, M ;
KOZAKI, K ;
MORI, N ;
ISHIBASHI, S ;
SHIMANO, H ;
TAKAKU, F ;
YAZAKI, Y ;
FURUICHI, Y ;
MURASE, T .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1856-1864